Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Chelsea Therapeutics International, Ltd. (CHTP) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $4.72 Metrics
OS: 78.9 M
Market cap: $373 M
Net cash: $37.1 M $0.47 per share
EV: $335 M

 
TTM Valuation
EBITDA ($13.3) M
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06
Revenues0.00.00.00.024.027.112.36.9
            Revenue growth   -100.0%-11.5%119.8%79.7%24.5%
Cost of goods sold0.00.00.00.06.45.316.59.5
Gross profit0.00.00.00.017.621.8-4.2-2.7
            Gross margin    73.5%80.5%-33.8%-38.9%
Selling, general and administrative        
Sales and marketing1.17.28.12.52.31.61.30.6
Research and development10.416.737.330.9    
General and administrative5.05.75.34.24.13.72.92.0
EBIT-16.4-29.6-50.6-37.5-30.4-32.4-16.5-9.5
            EBIT margin    -126.5%-119.5%-133.8%-138.9%
Pre-tax income-16.4-31.7-50.5-37.3-25.8-35.1-15.1-8.7
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-16.4-31.7-50.5-37.3-25.8-35.1-15.1-8.7
            Net margin    -107.4%-129.4%-122.3%-126.3%
 
Diluted EPS($0.24)($0.47)($0.84)($0.91)($0.82)($1.17)($0.66)($0.46)
Shares outstanding (diluted)68.866.960.141.231.530.022.918.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy